Ignacio Garrido‐Laguna
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 60
- Colorectal Cancer Treatments and Studies 34
- Cancer Immunotherapy and Biomarkers 23
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 47
-
- Lung Cancer Treatments and Mutations 23
- Gastric Cancer Management and Outcomes 16
- Advanced Breast Cancer Therapies 15
- Molecular Biology top 5%
-
- Neuroendocrine Tumor Research Advances 15
- Co-authors
- Manuel HidalgoRazelle KurzrockFilip JankúChris Nevala-PlagemannDavid S. HongAung NaingSiqing FuGerald S. Falchook
- Journals
- Journal of Clinical Oncology (49 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Ignacio Garrido‐Laguna
155 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 3.1k
- Cancer Research 1.5k
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 516
- Molecular Biology 1.8k
Countries citing papers authored by Ignacio Garrido‐Laguna
This map shows the geographic impact of Ignacio Garrido‐Laguna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Garrido‐Laguna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Garrido‐Laguna more than expected).
Fields of papers citing papers by Ignacio Garrido‐Laguna
This network shows the impact of papers produced by Ignacio Garrido‐Laguna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Garrido‐Laguna. The network helps show where Ignacio Garrido‐Laguna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ignacio Garrido‐Laguna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 70 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 46 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 20 | |
| 15 | 2018 | 17 | |
| 16 | 2011 | 289 | |
| 17 | 2011 | 179 | |
| 18 | 2011 | 303 | |
| 19 | 2010 | 14 | |
| 20 | Activity of the T-type calcium channel antagonist Mibefradil in pancreatic cancer xenografts | 2008 | 4 |
About Ignacio Garrido‐Laguna
Ignacio Garrido‐Laguna is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 160 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (60 papers), Cancer Genomics and Diagnostics (47 papers), Colorectal Cancer Treatments and Studies (34 papers), Lung Cancer Treatments and Mutations (23 papers), Cancer Immunotherapy and Biomarkers (23 papers), Gastric Cancer Management and Outcomes (16 papers), Advanced Breast Cancer Therapies (15 papers) and Neuroendocrine Tumor Research Advances (15 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (1.5k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Ignacio Garrido‐Laguna has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Manuel Hidalgo, Razelle Kurzrock, Filip Jankú, Chris Nevala-Plagemann, David S. Hong, Aung Naing, Siqing Fu, Gerald S. Falchook, Apostolia M. Tsimberidou and Benjamin L. Solomon. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.